SPRO → $6.00 by Sep 3, 2026.

Spero (currently trading at $3) is this tiny biotech firm with a pretty cool drug called tebipenem. It’s an oral carbapenem antibiotic for gnarly urinary tract infections. Anyways, everyone's holding their breath for June 18th as that’s when the FDA’s gonna make their ruling on tebipenem. Unlike most small companies, Spero has GlaxoSmithKline (GSK) managing the drug's development & sales outside the US. If the FDA gives the green light, Spero doesn’t have to assemble a massive sales team. Rather, …